Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02934464
Title Assessment of Ramucirumab Plus Paclitaxel as Switch MANteInance Versus Continuation of First-line Chemotherapy in Patients With Advanced HER-2 Negative Gastric or Gastroesophageal Junction Cancers (ARMANI)
Recruitment Unknown status
Gender both
Phase Phase III
Variant Requirements No
Sponsors Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Age Groups: adult | senior
Covered Countries ITA

Facility Status City State Zip Country Details
Maria Di Bartolomeo RECRUITING Milan 20133 Italy Details
*Shaded cells indicate that there was no data available from for the field